SEE IF YOU QUALIFY
If you’re interested in reserving an exclusive VIP spot at the CGT Manufacturing Partnerships Select, reach out to us before spots fill up – Only 25 spots available.
CGT Manufacturing Partnerships Select
Setting The Manufacturing Standard For Cell And Gene Therapy Success
September 07 - 08, 2021 | Virtual Forum
Event takes place in Eastern Time Zone
Event takes place in Eastern Time Zone
BENCHMARK WITH THE BEST
Peter Marks MD, PhD
Director, Center for Biologics Evaluation and Research (CBER)
Food and Drug Administration (FDA)
John Tomtishen
Director of Manufacturing, Technical Operations
Legend Biotech
Craig Malzahn
Head of Technical Operations
REGENXBIO Inc.
Kelly Quesada
Vice President, Head of Quality
Homology Medicines
Dan Bright
Senior Global Project Manager
Ferring Pharmaceuticals
Steven Goodman
Senior Director, AAV Process Development and Manufacturing
Vertex Pharmaceuticals
Fouad Atouf
Vice President, Global Biologics
USP
Thomas Page
Associate Vice President of Engineering and Asset Development
FUJIFILM Diosynth Biotechnologies
WHAT YOU CAN EXPECT
While all biopharma companies have been affected by the COVID-19 pandemic, the complex manufacturing model as well as supply chain disruptions and demand for source materials mean that many Cell & Gene Therapy companies have been hit especially hard.
From September 7-8, CGT Manufacturing Select will bring together senior leaders in CGT manufacturing and technical operations to develop practical insight on the impact of the global pandemic on day-to-day operations. Participants will also address the continuing challenge of manufacturing bottlenecks, benchmark with peers on how to leverage value in internal/external manufacturing networks, and how industry can develop standards that improve quality, optimize process development and establish cGMP to deliver life changing therapies to patients.
Participants can benchmark against the best-in-class across these key areas:
- Designing a manufacturing network around predictability, stability, and fast turnaround times
- Securing critical materials and ingredients for the manufacturing of CGT
- Creating the cell therapy value chain via IT advances, smart technologies and decentralized approaches
- Meeting regulatory requirements and ensuring quality for cell and gene therapy manufacturing
WHAT MAKES A SELECT DIFFERENT
By Invite Only
Participation is strictly limited to executives from leading corporations to facilitate true peer-level networking
Tailored Itinerary
Only attend the topics and meet the peers aligned with your current business objectives
Strategic Content
The intellectual content of the agenda is specifically designed for the seniority and maturity of the participants
Meetings
Cut out the noise of a crowded market. Meet only with senior solutions providers to discuss your strategic needs
SPONSORS INCLUDE
SPONSORSHIP OPPORTUNITIES
If you’re interested in discussing CGT Manufacturing Partnerships Select sponsorship opportunities, contact us at enquiry@unitelifesciences.com
Meet With Qualified Buyers
Meet With Qualified Buyers
Our format has been built to pair you with qualified decision makers looking for the solutions you provide. Don't miss out on the opportunity schedule 1-1 meetings with your top prospects.
Be Front of Mind
Be Front of Mind
Our speaking opportunities will help break through the noise from a crowded marketplace, establish credibility, position you as a trusted advisor and fast track the discovery phase
In Partnership With :
QUESTIONS?
Contact us: 1-800-882-8684
Email: enquiry@iqpc.com
©2024 IQPC. All rights reserved.
